
Opinion|Videos|April 16, 2024
Harnessing Continuous Glucose Monitors for Type 1 Diabetes Management + Closing Words
Robert Gabbay, MD, PhD, gives closing thoughts and advocates that continuous glucose monitors should be supplied for all insulin-dependent diabetes patients, including at initial diagnosis, to facilitate self-management and tighter control of this disease.
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
AI in Health Care Could Improve Accuracy, Efficiency, and Outcomes: Amrita Basu, PhD
2
Cardio-Oncology Collaboration Could Reduce Cardiovascular, Breast Cancer Risks: Eric H. Yang, MD
3
Top 5 Trending FDA Approvals of 2025
4
Number of Medicare Beneficiaries With HIV Expected to Double in Next Decade
5








































